FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment
WebJanuary 06, 2023. Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the …
DA: 22 PA: 44 MOZ Rank: 46